A detailed history of Envestnet Asset Management Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 27,840 shares of HRTX stock, worth $43,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,840
Previous 19,157 45.33%
Holding current value
$43,152
Previous $67,000 17.91%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1.73 - $3.67 $15,021 - $31,866
8,683 Added 45.33%
27,840 $55,000
Q2 2024

Aug 08, 2024

BUY
$2.32 - $3.86 $2,686 - $4,469
1,158 Added 6.43%
19,157 $67,000
Q1 2024

May 13, 2024

BUY
$1.71 - $3.06 $7,824 - $14,002
4,576 Added 34.09%
17,999 $49,000
Q4 2023

Feb 13, 2024

BUY
$0.54 - $1.82 $1,777 - $5,989
3,291 Added 32.48%
13,423 $22,000
Q3 2023

Nov 13, 2023

BUY
$0.97 - $1.8 $9,828 - $18,237
10,132 New
10,132 $10,000
Q1 2022

May 04, 2022

SELL
$4.63 - $9.94 $54,615 - $117,252
-11,796 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$8.35 - $12.6 $98,496 - $148,629
11,796 New
11,796 $108,000
Q1 2020

Apr 23, 2020

SELL
$10.23 - $24.56 $566,803 - $1.36 Million
-55,406 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$17.42 - $26.61 $42,278 - $64,582
2,427 Added 4.58%
55,406 $1.3 Million
Q3 2019

Oct 17, 2019

BUY
$16.36 - $21.39 $69,480 - $90,843
4,247 Added 8.72%
52,979 $980,000
Q2 2019

Aug 02, 2019

SELL
$16.93 - $26.22 $37,246 - $57,684
-2,200 Reduced 4.32%
48,732 $906,000
Q1 2019

May 10, 2019

BUY
$23.15 - $28.34 $139,988 - $171,371
6,047 Added 13.47%
50,932 $1.25 Million
Q4 2018

Feb 13, 2019

BUY
$22.03 - $32.01 $988,816 - $1.44 Million
44,885 New
44,885 $1.16 Million
Q3 2018

Nov 14, 2018

SELL
$30.0 - $40.85 $40,110 - $54,616
-1,337 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$26.4 - $42.0 $52 - $84
-2 Reduced 0.15%
1,337 $52,000
Q1 2018

May 09, 2018

BUY
$18.43 - $28.8 $24,677 - $38,563
1,339 New
1,339 $37,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.